|
|||||||||
|
| OC Member | Affiliation/Company |
| BAI, Xu | Changchun Discovery Sciences, Ltd. China |
| CAI, Sui Xiong | Maxim Pharmaceutical |
| CHEN, Ping | Pfizer |
| CHENG, David | Pfizer |
| FAN, Nancy | Idec Pharmaceutical |
| FEN, Jian Bing | Illumina |
| GAO, Xia | Structural Genomics |
| GU, Guibao | Merck |
| GU, Yin | Johnson & Johnson |
| GUO, Ming | Pfizer |
| GUO, Richard | Pfizer |
| HOU, Xinjun | Pfizer |
| HUANG, Shi | Burnham Institute |
| HE, Huaping (Jeff) | MitoKor |
| HE, Yun | Genomics Institute of Novartis Research Foundation |
| JIANG, Cecilia | Genomics Institute of Novartis Research Foundation |
| JIANG, Cheng | |
| Liao, Xiaoxing | Pfizer |
| LI, Bin | Anadys |
| LI, Hui | Pfizer |
| LI, Rongshi | ChemBridge Research Laboratories |
| LI, Shihong | Pfizer |
| LI, Ying | Pfizer |
| LIN, Fen-fen | Merck |
| LUO, Lin | Johnson & Johnson |
| LUO, Sam | GenWay Biotech, Inc. |
| SHI, Michael | Sequenom |
| SHI, Wei-Xing | Johnson & Johnson |
| SU, Austin | Syngenta |
| TAO, Anping | La Jolla Pharmaceutical |
| WANG, Wen | Pfizer |
| WANG, Xudong | Johnson & Johnson |
| WU, Lei | Aviva Biosciences |
| WU, Zhen Ping | Pfizer |
| XIE Weilin | Signal Pharmaceutical (Celgene) |
| XU Jian | Structural Genomics |
| XU, Kun | Syrrx |
| XU, Lifen | Maxim Pharmaceutical |
| YAN, Eric | Pfizer |
| YU, Lin | Triad Therapeutics |
| YU, Xiu | Pfizer |
| YUAN, Jason | UCSD |
| ZENG, Fuyue | Arena Pharmaceutical |
| ZHANG, Howard | Combi-Blocks |
| ZHANG, Kanying | Genomics Institute of Novartis Research Foundation |
| ZHANG, Shaohui | Tanabe Research Laboratories |
| ZHANG, Zhuohua | Burnham Institute |
| ZHAO, Chanfeng | lllumina |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||
